STOCK MARKET BSE NSE

New Biomarker for Breast and Prostate Cancers Found

Researchers have identified a genetic biomarker responsible for progression of many breast and prostate cancers.

Published: 08th August 2015 12:56 PM  |   Last Updated: 08th August 2015 12:56 PM   |  A+A-

By IANS

NEW YORK: Researchers have identified a novel genetic biomarker responsible for the progression of many breast and prostate cancers.

The finding could bolster efforts to better identify patients who respond to certain types of chemotherapy drugs that attack the most aggressive forms of cancer.

"Understanding and identifying biomarkers is a vital step toward cancer research and care," said lead study author Michael Freeman from Cedars-Sinai Medical Centre in Los Angeles, California, US.

"New profiling strategies exemplified by this study will ultimately improve our ability to treat cancer patients," Freeman noted.

The newly identified genetic biomarker - diaphanous- related formin-3 or DIAPH3 - participates in a protein interaction that makes cells rigid.

The study found that when this biomarker is lost or lowered, cells become "deformable," squeezing through tissue spaces, causing disease growth or progression.

The study was published in the journal Scientific Reports.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp